Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2005
06/16/2005WO2005053640A2 Azithromycin multiparticulate dosage forms by liquid-based processes
06/16/2005WO2005053639A2 Controlled release multiparticulates formed with dissolution enhancers
06/16/2005WO2005053638A2 Composition and delivery system
06/16/2005WO2005053637A2 Pharmaceutical spray formulation comprising a hypro fluor alkane amd an acylated cyclodextrin
06/16/2005WO2005053636A2 Cosmetic and dermatological oxygen carrier system
06/16/2005WO2005053617A2 Compositions and methods comprising collagen
06/16/2005WO2005053612A2 Micellar systems useful for delivery of lipophilic or hydrophobic compounds
06/16/2005WO2005053608A2 Preparing for individualized dosage forms of medicaments
06/16/2005WO2005053605A2 Therapeutic liposomes
06/16/2005WO2005053599A1 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing
06/16/2005WO2005053444A1 Inhaler for basic pharmaceutical agents and method for production thereof
06/16/2005WO2005041976A3 Injectable gabapentin compositions
06/16/2005WO2005040105A3 Novel surfactants and applications thereof
06/16/2005WO2005039642B1 Dna delivery with gemini cationic surfactants
06/16/2005WO2005039528A3 Composition for the treatment of arthrosis/arthritis, especially for treating joints
06/16/2005WO2005037188A3 Therapeutic agent for periodontal disease
06/16/2005WO2005027832A3 Edta containing compositions and uses thereof
06/16/2005WO2005023227A3 Nicotine formulations and use thereof
06/16/2005WO2005023181A3 Polymeric systems for controlled drug therapy
06/16/2005WO2005020962A8 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
06/16/2005WO2005013937A3 Novel compositions of sildenafil free base
06/16/2005WO2005009381A3 Immediate-release formulation of acid-labile pharmaceutical compositions
06/16/2005WO2005007284A3 Composite nanoparticles
06/16/2005WO2005007117A3 Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
06/16/2005WO2005007098A3 Nucleic acid therapy to enhance cartilage repair
06/16/2005WO2005002554A3 A method of promoting sleep using topical administration of vasoactive agents
06/16/2005WO2005000280A3 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
06/16/2005WO2004112836A3 Ophthalmic compositions containing a synergistic combination of two polymers
06/16/2005WO2004108165A3 Magnetic nanoparticles linked to a lingand
06/16/2005WO2004105727A3 Stabilized pharmaceutical product
06/16/2005WO2004093643B1 Magnetically controllable drug and gene delivery stents
06/16/2005US20050131532 Apparatus and methods for controlled substance delivery from implanted prostheses
06/16/2005US20050131458 Biodegradable embolic agents
06/16/2005US20050131389 Osmotic delivery system flow modulator apparatus and method
06/16/2005US20050131388 Embedded spinal injector
06/16/2005US20050131386 Method and device for minimally invasive implantation of biomaterial
06/16/2005US20050131363 Fiber substrate with odor absorbent
06/16/2005US20050131337 Analgesic drug delivery; skin discolroation inhibition
06/16/2005US20050131225 Biodegradable oxidized cellulose esters and their uses as microspheres
06/16/2005US20050131200 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines
06/16/2005US20050131079 Powder mixture with water; therapy for infections, inflammation of ears, throat
06/16/2005US20050131072 Bronchodilator; side efect reduction
06/16/2005US20050131071 Orodispersible pharmaceutical composition of agomelatine
06/16/2005US20050131064 Administering powder or aerosol to nasal mucous membrane
06/16/2005US20050131054 Test system for evaluating the compatibility of biologically active substances with copolymers
06/16/2005US20050131031 Blending measure concentration of nicotine into solution ; accuray dosage
06/16/2005US20050131027 Fine particle size pioglitazone
06/16/2005US20050131025 In situ applying to eye
06/16/2005US20050130975 Phthalazine, hydralazine derivative; antihypertensive; extended shell life
06/16/2005US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD)
06/16/2005US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
06/16/2005US20050130932 Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution; eye drops; bioresorbable; antibacterial properties
06/16/2005US20050130930 Adenosine derivatives and use thereof
06/16/2005US20050130900 Sustained release drug formulations containing a carrier peptide
06/16/2005US20050130827 Decomposable monotithic ceramic materials having an at least bimodal pore distribution and active metal centers located in the pores
06/16/2005US20050129806 Hydrolysis of pyrodextrin with amylase; chewing gum, candy, drugs
06/16/2005US20050129781 Colonic purgative composition with soluble binding agent
06/16/2005US20050129778 Pharmaceutical composition containing water soluble drug
06/16/2005US20050129777 Liquid phase emulsion upon dilution; controlling particle size; drug delivery; anticancer agents; pain maintenance ; immunosuppressant; antidiabetic agents
06/16/2005US20050129776 Microparticles supporting cells and active substances
06/16/2005US20050129775 Ferromagnetic particles and methods
06/16/2005US20050129774 Mixture with surfactant and another drug; analgesics; antiinflammatory agents
06/16/2005US20050129773 Acne; skin disorders; controlling particle sizes
06/16/2005US20050129771 Ophthalmic compositions containing a polysaccharide/borate gelling system
06/16/2005US20050129770 Topical applying to eye; lubricant; artificial tears
06/16/2005US20050129769 Hydrophilic polymeric nanoparticles; scaffold for drug; using n-cystinebisacrylamide
06/16/2005US20050129768 Using a oxyamidine phenyl compound as leukotriene antagonist
06/16/2005US20050129767 Antifungal formulation and manufacturing method thereof
06/16/2005US20050129765 Exterior semipermeable membrane with aperture; antidiabetic agents; eating disorders; antidiabetic agents; headaches
06/16/2005US20050129764 Antiarthritic agents; antiinflammatory agents; bronchitis; skin disorders; inflamamtory bowel disorders; cyclooxygenase inhibitors
06/16/2005US20050129763 Systems, methods and apparatuses for manufacturing dosage forms
06/16/2005US20050129762 Oral delivery to mammals; venlafaxine ; antidepressants; anxiolytic agents
06/16/2005US20050129761 Pantoprazole multiparticulate formulations
06/16/2005US20050129760 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
06/16/2005US20050129759 Sustained release compositions and controlled delivery method
06/16/2005US20050129758 Dietary fiber delivery system
06/16/2005US20050129757 Process for producing solid dosage forms
06/16/2005US20050129756 UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
06/16/2005US20050129755 Ingestible capsules containing ethanol
06/16/2005US20050129754 Halogenated anesthetic in emulsion with lecithin
06/16/2005US20050129753 Protonation therapy agent; transdermal gradient; complex of gluconic acid, ammonium compound and adriamycin
06/16/2005US20050129752 Mammal therapy for pancreatic cancer
06/16/2005US20050129751 Controlled release of drug
06/16/2005US20050129750 Process for producing liposome suspension and product containing liposome suspension produced thereby
06/16/2005US20050129749 Multi-layer transdermal drug delivery device
06/16/2005US20050129748 Multilayer transdermal laminate patch with backing, adhesive
06/16/2005US20050129746 Orally ingestible carriers; accurate dosage
06/16/2005US20050129744 Methods and compositions for treating skin wounds
06/16/2005US20050129742 Antimicrobial article with diffusion control layer
06/16/2005US20050129737 Devices and methods for pain management
06/16/2005US20050129736 Compositions and methods for treating or preventing diseases of body passageways
06/16/2005US20050129734 Hydrogel entrapping therapeutic agent and stent with coating comprising this
06/16/2005US20050129732 Biodegradable, antibiotic, controlled release tape
06/16/2005US20050129728 A mini-implant including a silicone support material, at leaast one drug and carrier in or on a silicone support rod; the mini-implant providing a predetermined threshold blood level of pharmaceutical active for treatment of a selected indication;improved drug carrying capacity
06/16/2005US20050129727 Drug core encapsulated with multilayer polyelectrolyte shells
06/16/2005US20050129723 Skin care composition that mediates cell to cell communication
06/16/2005US20050129722 For an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising a fatty acid, cholesterol, a ceramide and at least one skin lipid precursor; topical drug delivery
06/16/2005US20050129721 Refrigerant composition, refrigerant auxiliary compositions and uses thereof
06/16/2005US20050129718 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
06/16/2005US20050129714 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
1 ... 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 ... 2991